| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (RN4220 + pVGA) |
- |
- |
32 － ? |
Lincomycin (Lincocin)  |
601 |
| Staphylococcus aureus (RN4220 + pVGA) |
- |
- |
32 － ? |
Retapamulin |
601 |
| Staphylococcus aureus (RN4220 + pVGA) |
- |
- |
>64 － ? |
Tiamulin (Tiamuline, Tiamutilin) |
601 |
| Staphylococcus aureus (RN4220 + pYH4 vector + aTc inducer) |
- |
- |
0.06 － ? |
Mupirocin (Bactroban) |
789 |
| Staphylococcus aureus (RN4220 + pYH4 vector + aTc inducer) |
- |
- |
0.08 － ? |
REP8839 |
789 |
| Staphylococcus aureus (RN4220 + pYH4 vector + aTc inducer) |
- |
- |
0.25 － ? |
Novobiocin (Albamycin) |
789 |
| Staphylococcus aureus (RN4220 + pYH4 vector + aTc inducer) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
789 |
| Staphylococcus aureus (RN4220 + pYH4 vector) |
- |
- |
0.008 － ? |
REP8839 |
789 |
| Staphylococcus aureus (RN4220 + pYH4 vector) |
- |
- |
0.06 － ? |
Mupirocin (Bactroban) |
789 |
| Staphylococcus aureus (RN4220 + pYH4 vector) |
- |
- |
0.25 － ? |
Novobiocin (Albamycin) |
789 |
| Staphylococcus aureus (RN4220 + pYH4 vector) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
789 |
| Staphylococcus aureus (RN4220 + pYH4-met(S)) |
- |
- |
0.06 － ? |
Mupirocin (Bactroban) |
789 |
| Staphylococcus aureus (RN4220 + pYH4-met(S)) |
- |
- |
0.12 － ? |
REP8839 |
789 |
| Staphylococcus aureus (RN4220 + pYH4-met(S)) |
- |
- |
0.25 － ? |
Novobiocin (Albamycin) |
789 |
| Staphylococcus aureus (RN4220 + pYH4-met(S)) |
- |
- |
0.5 － ? |
Vancomycin (Vancocyn, Lyphocin) |
789 |
| Staphylococcus aureus (RN4220 + pYH4-metS + aTc inducer) |
- |
- |
0.006 － ? |
Mupirocin (Bactroban) |
789 |
| Staphylococcus aureus (RN4220 + pYH4-metS + aTc inducer) |
- |
- |
0.25 － ? |
Novobiocin (Albamycin) |
789 |
| Staphylococcus aureus (RN4220 + pYH4-metS + aTc inducer) |
- |
- |
0.5 － ? |
Vancomycin (Vancocyn, Lyphocin) |
789 |
| Staphylococcus aureus (RN4220 + pYH4-metS + aTc inducer) |
- |
- |
1 － ? |
REP8839 |
789 |
| Staphylococcus aureus (RN4220 Δmut(S)) |
- |
- |
0.5 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
280 |
| Staphylococcus aureus (RN4220 Δmut(S)) |
- |
- |
0.5 － ? |
RWJ-416457 |
280 |
| Staphylococcus aureus (RN4220) |
- |
- |
≤0.06 － ? |
Clindamycin (Cleocin) |
601 |
| Staphylococcus aureus (RN4220) |
- |
- |
≤0.06 － ? |
Retapamulin |
601 |
| Staphylococcus aureus (RN4220) |
- |
- |
0.125 － ? |
Levofloxacin (Levaquin, Quixin) |
601 |
| Staphylococcus aureus (RN4220) |
- |
- |
0.125 － ? |
Quinupristin/Dalfopristin (Synercid) |
601 |
| Staphylococcus aureus (RN4220) |
- |
- |
0.25 － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
601 |
| Staphylococcus aureus (RN4220) |
- |
- |
0.25 － ? |
Tetracycline (Sumycin, Achromycin V, Steclin) |
601 |
| Staphylococcus aureus (RN4220) |
- |
- |
0.5 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
280 |